Inhibition of FABP5 attenuates inflammatory bowel disease by modulating macrophage alternative activation

Autor: Xu, Jingping a, b, 1, Zheng, Bolin c, 1, Xie, Chunlan d, 1, Zhao, Yao a, b, Wu, Hailun e, Wang, Yiting a, b, Guan, Xiaoli a, b, Lei, Xintao a, b, Liu, Dexin c, Lou, Xiaoying a, b, Chen, Xiaohui f, ⁎, Huang, Yan a, b, ⁎
Zdroj: In Biochemical Pharmacology January 2024 219
Databáze: ScienceDirect